Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03603886 · ClinicalTrials.gov registry record · NA

Adolescent Cancer Telemedicine for Pain Management

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT03603886 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03603886, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

Pain in adolescents undergoing treatment for cancer is a common problem, often related to treatment or to the cancer itself. Due to increasing outpatient-based cancer treatment, the burden of care and pain management has shifted to the home environment. Yet, there are limited interventions that target the management of pain at home. Adolescence is marked by increased need for independence and social integration, both of which can be impaired by pain or fear of pain. To address unique needs during this developmental period, this study will test a telemedicine program to enhance pain knowledge and pain control strategies in adolescents ages 12-21 years who are undergoing treatment for cancer. Fifty-six teens will be randomized to an intervention or wait-list control condition. Patients randomized to the waitlist control condition will receive the intervention following completion of the waitlist condition. The intervention will consist of four weekly 30-45 minute telemedicine (online via videoconferencing platform) sessions with a trained social work or psychology provider. Sessions will focus on pain psychoeducation, coping tools, communication, and stress management. Participants will complete online questionnaires assessing pain coping, pain management, and pain-related impairment at pre-intervention, post-intervention, and 1- and 2-month follow-up.

Interventions

  • BEHAVIORAL Telemedicine Pain Management Intervention (immediate group)
  • BEHAVIORAL Telemedicine Pain Management Intervention (waitlist group, intervention administered following 4-week waitlist period)

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-05-03
Est. Completion 2020-07-01
Phase NA

What the Registry Record Tells You About NCT03603886

The ClinicalTrials.gov registry entry for NCT03603886 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Telemedicine Pain Management Intervention (immediate group) is the first listed.

NCT03603886 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03603886 about?

NCT03603886 is a clinical study titled "Adolescent Cancer Telemedicine for Pain Management". Pain in adolescents undergoing treatment for cancer is a common problem, often related to treatment or to the cancer itself. Due to increasing outpatient-based cancer treatment, the burden of care and pain management has shifted to the home environment. Yet, there are limited interventions that targ...

What is the current status of trial NCT03603886?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-05-03. Estimated completion is 2020-07-01.

What interventions are being tested in trial NCT03603886?

The interventions under investigation include: Telemedicine Pain Management Intervention (immediate group) (BEHAVIORAL), Telemedicine Pain Management Intervention (waitlist group, intervention administered following 4-week waitlist period) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03603886?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.